Physician

Scott Pham, M.D.

According to 2025 Medicare claims, Scott Pham, M.D. (NPI: 1558366500) practices cardiac electrophysiology in the Sioux Falls, SD-MN market, with the plurality of this provider's patient population coming from Minnehaha, SD. This provider's primary affiliated billing organization is SANFORD MEDICAL CENTER (NPI: 1093090342; TIN: 460227855) and primary practice location at 57105-0401. Pham is affiliated with the Prairie Vista Care Organization (ACO ID: A3578), Avera Prairie View ACO (ACO ID: A4692), Caravan Health ACO 43 LLC (ACO ID: A4974), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Pham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,953 traditional Medicare patients, billed 7,852 HCPCS/CPT codes, and received $412,159 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,204 prescription claims across 292 beneficiaries totaling $49,746 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 2 records totaling $4,900. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $152,202 to $49,746. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,085	8,197	$529,332
2016	2,139	8,731	$516,850
2017	2,204	8,887	$493,848
2018	2,333	9,046	$487,123
2019	2,535	9,793	$518,417
2020	2,437	9,943	$509,235
2021	2,386	9,765	$528,720
2022	2,246	8,775	$440,851
2023	2,247	8,499	$433,224
2024	1,953	7,852	$412,159

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	696	2,995	$152,202
2016	724	2,924	$159,777
2017	597	2,487	$148,289
2018	586	2,488	$154,450
2019	553	2,465	$133,156
2020	481	2,231	$183,345
2021	441	1,783	$87,082
2022	341	1,418	$52,274
2023	297	1,147	$50,243
2024	292	1,204	$49,746

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	758	888	$67
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	410	428	$48
93295	Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days	446	1,217	$23
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	385	1,017	$19
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	339	360	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	20	993	$19,014
Xarelto	Rivaroxaban	14	600	$10,825
Repatha Sureclick	Evolocumab	13	364	$7,234
Warfarin Sodium	Warfarin Sodium	497	32,065	$4,349
Jantoven	Warfarin Sodium	380	21,591	$2,997

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$4,900	Abbott Laboratories
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Scott Pham, M.D.?

Tedicare shows public-source Medicare data for Scott Pham, M.D. (NPI 1558366500), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott Pham, M.D. have ACO affiliation data?

Scott Pham, M.D. is shown with ACO affiliation data for Prairie Vista Care Organization (MSSP, ACO ID A3578), Avera Prairie View ACO (MSSP, ACO ID A4692), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Scott Pham, M.D.?

Scott Pham, M.D. is linked to SANFORD MEDICAL CENTER (billing NPI 1093090342) in the available physician profile data.

Does Scott Pham, M.D. have Open Payments data?

Scott Pham, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.